This phenomenon has been described in insulin-treatment naïve people presenting with hypoglycaemic episodes (described as insulin autoimmune syndrome (IAS) or Hirata disease [26]) as well as in patients with labile diabetes treated with modern genetically engineered insulin analogues. Here, INS is linked to diabetes mellitus.